Inspire Medical Systems shares are up today on third-quarter results that came in ahead of the consensus forecast.

Inspire Medical Systems topped Q3 expectations, signaling continued market strength and innovation.

Among potential surgeries for sleep apnea is UPPP (uvulopalatopharyngoplasty) surgery, which involves removing part of the ...

When someone has sleep apnoea, their breathing stops repeatedly during sleep. Physiologically speaking, the front wall of the ...

H.C. Wainwright analyst Edward White has reiterated their bullish stance on NYXH stock, giving a Buy rating on November 5. Edward White has ...

The technology company has filed a patent for an innovative "smart pillow" aimed at treating obstructive sleep apnea (OSA). If snoring noises are detected, air chambers change the position of the ...

A common yet underdiagnosed sleep disorder contributes to the development of dementia among adults -; particularly women, a ...

minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR and PDMA-approved neurostimulation technology of ...

Do you suffer from sleep apnea and long for a peaceful night’s sleep and solution to your snoring? Holy Cross Medical Group pulmonologist Ronald Scott, M.D. will speak about Inspire®, an FDA-approved ...

Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with ...